GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytophage Technologies Ltd (TSXV:CYTO) » Definitions » Accounts Payable

Cytophage Technologies (TSXV:CYTO) Accounts Payable : C$0.27 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Cytophage Technologies Accounts Payable?

Cytophage Technologies's Accounts Payable for the quarter that ended in Mar. 2024 was C$0.27 Mil.

Cytophage Technologies's quarterly Accounts Payable declined from Sep. 2023 (C$0.14 Mil) to Dec. 2023 (C$0.01 Mil) but then increased from Dec. 2023 (C$0.01 Mil) to Mar. 2024 (C$0.27 Mil).

Cytophage Technologies's annual Accounts Payable increased from Dec. 2021 (C$0.01 Mil) to Dec. 2022 (C$0.11 Mil) but then declined from Dec. 2022 (C$0.11 Mil) to Dec. 2023 (C$0.01 Mil).

Cytophage Technologies Accounts Payable Historical Data

The historical data trend for Cytophage Technologies's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytophage Technologies Accounts Payable Chart

Cytophage Technologies Annual Data
Trend Dec21 Dec22 Dec23
Accounts Payable
0.01 0.11 0.01

Cytophage Technologies Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Accounts Payable Get a 7-Day Free Trial 0.11 - 0.14 0.01 0.27

Cytophage Technologies Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Cytophage Technologies Accounts Payable Related Terms

Thank you for viewing the detailed overview of Cytophage Technologies's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Cytophage Technologies (TSXV:CYTO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytophage Technologies Ltd (TSXV:CYTO) » Definitions » Accounts Payable
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Cytophage Technologies Ltd is a Canadian biotechnology company that uses molecular genetic techniques and synthetic biology to create effective bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. To combat dangerous bacteria company generates phages to address specific bacterial infections, including strains resistant to antibiotics. It has also developed a 'phage-display' methodology to develop vaccine-like products using bacteriophages for a number of potential applications in human and animal health.